Materials SARS-CoV-2 Therapeutics A Next-Generation mRNA Vaccine Platform For Enhancing T-Cell Responses And Improving Antiviral And Antitumor Immunity Next-generation mRNA vaccine platform uses a lipid-polymer hybrid nanoparticle to boost stability, immune cell uptake, and T cell responses, leading to stronger and longer-lasting… Interests: Biologics, Drug Delivery, Immunology, Immunotherapy, Microbiology/Virology, Oncology, Polymer, Vaccines Reference ID: 25-T-134 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics SARS-CoV-2 Therapeutics Point Of Care Technology For SARS-CoV-2 Detection and Neutralization SARS-CoV-2’s enters cells when the receptor binding domain (RBD) of its spike protein (S-protein) interacts with angiotensin-converting enzyme 2 (ACE2). In order to block… Interests: Antibody, Antibody Reference ID: 21-T-014 Desired Partnership: Co-development, Licensing IP: Patent Pending
Research Tools SARS-CoV-2 Therapeutics Neutralizing Monoclonal Antibodies Against SARS-CoV-2 The landscape of SARS-CoV-2 is experiencing a novel development of viral variants harboring mutations that can escape even the most highly potent antibodies against… Interests: Antibody, Antibody Reference ID: 22-T-070 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Research Tools SARS-CoV-2 Machine Learning-Based Prediction Of Viral Mutations From Genomic Sequences There have been significant research efforts to develop machine learning and predictive analytics based tools to predict viral evolution which remains the main obstacle… Interests: Bioinformatics, Bioinformatics, Machine Learning/Artificial Intelligence Reference ID: 21-T-011 Desired Partnership: Co-development, Licensing IP: Patent Pending
SARS-CoV-2 Therapeutics Drug Repurposing To Inhibit Nsp15 Endoribonuclease/NendU From SARS-CoV-2 There have been significant research efforts to develop various COVID-19 treatments. Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus… Interests: Infectious Disease, Small Molecules Reference ID: 20-T-062 Desired Partnership: Co-development, Licensing IP: Patent Issued
SARS-CoV-2 Therapeutics Hydrocarbon-Stapled Peptides To Inhibit SARS-CoV-2 Viral Infection The SARS-CoV-2 virus spreads by binding its spike protein to the human angiotensin-converting enzyme 2 (hACE2) protein expressed at the cell surface of lungs,… Interests: Infectious Disease Reference ID: 21-T-050 Desired Partnership: Co-development, Licensing IP: Patent Pending
SARS-CoV-2 Therapeutics Nanotraps for the containment and clearance of SARS-CoV-2 Inventors devised a nanomedicine termed “Nanotraps” that can completely capture and eliminate SARS-CoV-2 by triggering macrophages to engulf and clear the virus without becoming… Interests: Immunology, Immunotherapy, Infectious Disease Reference ID: 21-T-055 Desired Partnership: Licensing IP: Patent Pending
Diagnostics SARS-CoV-2 Therapeutics SARS-CoV-2 Monoclonal Antibodies Against Spike and Internal Proteins for Therapeutics and Diagnostics As of February 2021, there have been over 107 million cases and over 2 million deaths caused worldwide by the novel virus SARS-CoV-2. Few… Interests: Antibody, Antibody, Microbiology/Virology Reference ID: 21-T-040 Desired Partnership: Licensing IP: Patent Pending
